22
Views
89
CrossRef citations to date
0
Altmetric
Article

Aberrant Promoter Methylation of the ABCG2 Gene in Renal Carcinoma

, &
Pages 8572-8585 | Received 14 Apr 2006, Accepted 28 Aug 2006, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Takeshi Hirota, Toshihiro Tanaka, Hiroaki Takesue & Ichiro Ieiri. (2017) Epigenetic regulation of drug transporter expression in human tissues. Expert Opinion on Drug Metabolism & Toxicology 13:1, pages 19-30.
Read now
Elena Arrigoni, Sara Galimberti, Mario Petrini, Romano Danesi & Antonello Di Paolo. (2016) ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1419-1432.
Read now
Curtis D. Klaassen, Hong Lu & Julia Yue Cui. (2011) Epigenetic regulation of drug processing genes. Toxicology Mechanisms and Methods 21:4, pages 312-324.
Read now
Yi An & Weg M Ongkeko. (2009) ABCG2: the key to chemoresistance in cancer stem cells?. Expert Opinion on Drug Metabolism & Toxicology 5:12, pages 1529-1542.
Read now
Orsolya Polgar, Robert W Robey & Susan E Bates. (2008) ABCG2: structure, function and role in drug response. Expert Opinion on Drug Metabolism & Toxicology 4:1, pages 1-15.
Read now

Articles from other publishers (83)

Manasi S. Pote & Rajesh N. Gacche. (2023) ATP-binding cassette efflux transporters and MDR in cancer. Drug Discovery Today 28:5, pages 103537.
Crossref
Narayan Acharya & Kamaleshwar P. Singh. (2022) Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma. WIREs Mechanisms of Disease 14:6.
Crossref
Robert W. Robey, Sabrina Lusvarghi, Cindy H. Chau, Agnes Basseville, William D. Figg, Suresh V. Ambudkar & Susan E. Bates. 2022. Drug Transporters. Drug Transporters 235 256 .
Samiksha Kukal, Debleena Guin, Chitra Rawat, Shivangi Bora, Manish Kumar Mishra, Priya Sharma, Priyanka Rani Paul, Neha Kanojia, Gurpreet Kaur Grewal, Shrikant Kukreti, Luciano Saso & Ritushree Kukreti. (2021) Multidrug efflux transporter ABCG2: expression and regulation. Cellular and Molecular Life Sciences 78:21-22, pages 6887-6939.
Crossref
Katja Zappe & Margit Cichna-Markl. (2020) Aberrant DNA Methylation of ABC Transporters in Cancer. Cells 9:10, pages 2281.
Crossref
Arshad Mehmood, Liang Zhao, Muhammad Ishaq, Wang Xin, Lei Zhao, Chengtao Wang, Imam Hossen, Huimin Zhang, Yunhe Lian & Meili Xu. (2020) Anti-hyperuricemic potential of stevia ( Stevia rebaudiana Bertoni) residue extract in hyperuricemic mice . Food & Function 11:7, pages 6387-6406.
Crossref
Daniella Kovacsics, Anna Brózik, Borbála Tihanyi, Zsolt Matula, Adrienn Borsy, Nikolett Mészáros, Edit Szabó, Eszter Németh, Ábel Fóthi, Boglárka Zámbó, Dávid Szüts, György Várady, Tamás I. Orbán, Ágota Apáti & Balázs Sarkadi. (2020) Precision-engineered reporter cell lines reveal ABCG2 regulation in live lung cancer cells. Biochemical Pharmacology 175, pages 113865.
Crossref
Cissy Yong, Grant D. Stewart & Christian Frezza. (2019) Oncometabolites in renal cancer. Nature Reviews Nephrology 16:3, pages 156-172.
Crossref
Yujuan Zhang, Jinhu Huang, Xiangxiu Li, Ci Fang & Liping Wang. (2020) Identification of Functional Transcriptional Binding Sites within Chicken Abcg2 Gene Promoter and Screening Its Regulators. Genes 11:2, pages 186.
Crossref
Cong Huai, Yuqi Wei, Mo Li, Xiaoqing Zhang, Hao Wu, Xiaoyan Qiu, Lu Shen, Luan Chen, Wei Zhou, Na Zhang, Guanghui Zhu, Ying Zhang, Zhiruo Zhang, Lin He & Shengying Qin. (2019) Genome‐Wide Analysis of DNA Methylation and Antituberculosis Drug‐Induced Liver Injury in the Han Chinese Population . Clinical Pharmacology & Therapeutics 106:6, pages 1389-1397.
Crossref
García-Lino, Álvarez-Fernández, Blanco-Paniagua, Merino & Álvarez. (2019) Transporters in the Mammary Gland—Contribution to Presence of Nutrients and Drugs into Milk. Nutrients 11:10, pages 2372.
Crossref
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania & María Laura Ruiz. (2019) ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Current Medicinal Chemistry 26:7, pages 1224-1250.
Crossref
Feng-Lian Deng, Li Li & Zan-Song Huang. (2019) Role of breast cancer resistance protein in gastrointestinal tumors. World Chinese Journal of Digestology 27:6, pages 395-401.
Crossref
Noura Al-Zeheimi & Sirin A. Adham. 2019. Current Applications for Overcoming Resistance to Targeted Therapies. Current Applications for Overcoming Resistance to Targeted Therapies 131 159 .
Anna Reustle, Pascale Fisel, Olga Renner, Florian Büttner, Stefan Winter, Steffen Rausch, Stephan Kruck, Anne T. Nies, Jörg Hennenlotter, Marcus Scharpf, Falko Fend, Arnulf Stenzl, Jens Bedke, Matthias Schwab & Elke Schaeffeler. (2018) Characterization of the breast cancer resistance protein (BCRP/ ABCG2 ) in clear cell renal cell carcinoma . International Journal of Cancer 143:12, pages 3181-3193.
Crossref
Brittany N. Lasseigne & James D. Brooks. (2018) The Role of DNA Methylation in Renal Cell Carcinoma. Molecular Diagnosis & Therapy 22:4, pages 431-442.
Crossref
Jia-Feng Huang, Chun-Jie Wen, Guo-Zhi Zhao, Yi Dai, Ying Li, Lan-Xiang Wu & Hong-Hao Zhou. (2018) Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro. Cancer Chemotherapy and Pharmacology 82:2, pages 199-210.
Crossref
Ângela Marques-Magalhães, Inês Graça, Rui Henrique & Carmen Jerónimo. (2018) Targeting DNA Methyltranferases in Urological Tumors. Frontiers in Pharmacology 9.
Crossref
Toshihiro Tanaka, Takeshi Hirota & Ichiro Ieiri. (2018) Relationship between DNA Methylation in the 5′ CpG Island of the SLC47A1 (Multidrug and Toxin Extrusion Protein MATE1) Gene and Interindividual Variability in MATE1 Expression in the Human Liver . Molecular Pharmacology 93:1, pages 1-7.
Crossref
P. Jungsuwadee & M. Vore. 2018. Comprehensive Toxicology. Comprehensive Toxicology 617 666 .
Alison E. Fohner, Deanna J. Brackman, Kathleen M. Giacomini, Russ B. Altman & Teri E. Klein. (2017) PharmGKB summary. Pharmacogenetics and Genomics 27:11, pages 420-427.
Crossref
Inês Faleiro, Ricardo Leão, Alexandra Binnie, Ramon Andrade de Mello, Ana-Teresa Maia & Pedro Castelo-Branco. (2016) Epigenetic therapy in urologic cancers: an update on clinical trials. Oncotarget 8:7, pages 12484-12500.
Crossref
Kenneth K.W. To, Wing W. Leung & Simon S.M. Ng. (2017) A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development. Molecular Carcinogenesis 56:2, pages 464-477.
Crossref
Melanie Spitzwieser, Christine Pirker, Bettina Koblmüller, Georg Pfeiler, Stefan Hacker, Walter Berger, Petra Heffeter & Margit Cichna-Markl. (2016) Promoter methylation patterns of ABCB1 , ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients . Oncotarget 7:45, pages 73347-73369.
Crossref
N. Shenoy & L. Pagliaro. (2016) Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective. Annals of Oncology 27:9, pages 1685-1695.
Crossref
Juan Wang, Xiao-Xia Zhu, Lei Liu, Yu Xue, Xue Yang & He-Jian Zou. (2016) SIRT1 prevents hyperuricemia via the PGC-1α/PPARγ-ABCG2 pathway. Endocrine 53:2, pages 443-452.
Crossref
HYUN-HYE MOON, SUNG-HEE KIM & JA-LOK KU. (2016) Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines. Oncology Reports 35:1, pages 298-306.
Crossref
R Sun, B Jiang, H Qi, X Zhang, J Yang, J Duan, Y Li & G Li. (2015) SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2. Cell Death & Disease 6:11, pages e1990-e1990.
Crossref
Kenneth K.W. To, W.W. Leung & Simon S.M. Ng. (2015) Exploiting a novel miR-519c–HuR–ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer. Experimental Cell Research 338:2, pages 222-231.
Crossref
Kenneth K W To, Daniel C Poon, Yuming Wei, Fang Wang, Ge Lin & Liwu Fu. (2015) Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer. British Journal of Pharmacology 172:16, pages 4089-4106.
Crossref
Kenichi Ogasawara, Takahiro Osabe, Yumi Suzuki, Hatsue Tsuneyama, Kazumi Isa, Miho Kawai, Kumi Obara, Yoshiko Ogiyama, Shoichi Ito, Makoto Uchikawa, Masahiro Satake & Kenji Tadokoro. (2015) A new ABCG2 null allele with a 27-kb deletion including the promoter region causing the Jr(a−) phenotype . Transfusion 55:6pt2, pages 1467-1471.
Crossref
Qingcheng Mao & Jashvant D. Unadkat. (2014) Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update. The AAPS Journal 17:1, pages 65-82.
Crossref
Kazuhiro Satake, Yu Toyoda & Hiroshi Nakagawa. 2015. Resistance to Targeted ABC Transporters in Cancer. Resistance to Targeted ABC Transporters in Cancer 273 297 .
Alex Man Lai WuMingdong YangPooja DalviAndrei L. TurinskyWei WangDarci ButcherSean E. EganRosanna Weksberg, Patricia A. HarperShinya Ito. (2014) Role of STAT5 and epigenetics in lactation-associated upregulation of multidrug transporter ABCG2 in the mammary gland. American Journal of Physiology-Endocrinology and Metabolism 307:7, pages E596-E610.
Crossref
Xiao-kun Wang, Jie-hua He, Jing-hong Xu, Sheng Ye, Fang Wang, Hui Zhang, Zhen-cong Huang, Kenneth Kin Wah To & Li-wu Fu. (2014) Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem–like Cells. Cancer Research 74:16, pages 4431-4445.
Crossref
Agnes Basseville, Robert W. Robey, Julian C. Bahr & Susan E. Bates. 2014. Drug Transporters. Drug Transporters 187 221 .
L Schiefer, M Visweswaran, V Perumal, F Arfuso, D Groth, P Newsholme, S Warrier & A Dharmarajan. (2014) Epigenetic regulation of the secreted frizzled-related protein family in human glioblastoma multiforme. Cancer Gene Therapy 21:7, pages 297-303.
Crossref
Juan Liu, Cen Zhang, Meihua Lin, Wei Zhu, Yingjian Liang, Xuehui Hong, Yuhan Zhao, Ken H. Young, Wenwei Hu & Zhaohui Feng. (2014) Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma. Oncotarget 5:9, pages 2635-2647.
Crossref
In-Wha Kim, Nayoung Han, Gilbert J. Burckart & Jung Mi Oh. (2014) Epigenetic Changes in Gene Expression for Drug-Metabolizing Enzymes and Transporters. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:2, pages 140-150.
Crossref
Moritz C Oberstadt, Sandra Bien-Möller, Kerstin Weitmann, Susann Herzog, Katharina Hentschel, Christian Rimmbach, Silke Vogelgesang, Ellen Balz, Matthias Fink, Heike Michael, Jan-Philip Zeden, Henrike Bruckmüller, Anneke N Werk, Ingolf Cascorbi, Wolfgang Hoffmann, Dieter Rosskopf, Henry WS Schroeder & Heyo K Kroemer. (2013) Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme. BMC Cancer 13:1.
Crossref
Wook-Jin Yang, Min-Ji Song, Eun Young Park, Jong-Joo Lee, Joo-Hong Park, Keunhee Park, Jong Hoon Park & Hyoung-Pyo Kim. (2013) Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype. Molecules and Cells 36:4, pages 368-375.
Crossref
Kenji Oda, Tomohiro Nishimura, Kei Higuchi, Naomi Ishido, Kaori Ochi, Hisashi Iizasa, Yoshimichi Sai, Masatoshi Tomi & Emi Nakashima. (2013) Estrogen Receptor α Induction by Mitoxantrone Increases Abcg2 Expression in Placental Trophoblast Cells. Journal of Pharmaceutical Sciences 102:9, pages 3364-3372.
Crossref
Jumpei Saito, Takeshi Hirota, Shinji Furuta, Daisuke Kobayashi, Hiroshi Takane & Ichiro Ieiri. (2013) Association between DNA Methylation in the miR-328 5’-Flanking Region and Inter-individual Differences in miR-328 and BCRP Expression in Human Placenta. PLoS ONE 8:8, pages e72906.
Crossref
INKA ZOERNIG, CLAUDIA ZIEGELMEIER, BERND LAHRMANN, NIELS GRABE, DIRK JÄGER & NIELS HALAMA. (2013) Sequence mutations of the substrate binding pocket of stem cell factor and multidrug resistance protein ABCG2 in renal cell cancer: A possible link to treatment resistance. Oncology Reports 29:5, pages 1697-1700.
Crossref
V Martín, A M Sanchez-Sanchez, F Herrera, C Gomez-Manzano, J Fueyo, M A Alvarez-Vega, I Antolín & C Rodriguez. (2013) Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells. British Journal of Cancer 108:10, pages 2005-2012.
Crossref
Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper & Shinya Ito. (2013) Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells. Molecular Pharmacology 83:2, pages 377-388.
Crossref
Oliver Zolk, Rebecca Schnepf, Marc Muschler, Martin F. Fromm, Olaf Wendler, Maximilian Traxdorf, Heinrich Iro & Johannes Zenk. (2013) Transporter Gene Expression in Human Head and Neck Squamous Cell Carcinoma and Associated Epigenetic Regulatory Mechanisms. The American Journal of Pathology 182:1, pages 234-243.
Crossref
Xin-Gang WU, Shu-Bin PENG & Qian HUANG. (2012) Transcriptional regulation of breast cancer resistance protein. Hereditas (Beijing) 34:12, pages 1529-1536.
Crossref
Karthika Natarajan, Yi Xie, Maria R. Baer & Douglas D. Ross. (2012) Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochemical Pharmacology 83:8, pages 1084-1103.
Crossref
Mika Ikehata, Kumiko Ueda & Seigo Iwakawa. (2012) Different Involvement of DNA Methylation and Histone Deacetylation in the Expression of Solute-Carrier Transporters in 4 Colon Cancer Cell Lines. Biological and Pharmaceutical Bulletin 35:3, pages 301-307.
Crossref
Swathi Ramakrishnan & Roberto Pili. 2012. Renal Cell Carcinoma. Renal Cell Carcinoma 193 211 .
R R Singh, K Kunkalla, C Qu, E Schlette, S S Neelapu, F Samaniego & F Vega. (2011) ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Oncogene 30:49, pages 4874-4886.
Crossref
Patrick K. Campbell, Yang Zong, Shengping Yang, Sheng Zhou, Jeffrey E. Rubnitz & Brian P. Sorrentino. (2011) Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia. Leukemia Research 35:10, pages 1321-1329.
Crossref
Jianhui Yuan, Jianmeng Zhou, Nana Ji, Xinyun Xu, Jianjun Liu, Yuebin Ke, Jinquan Cheng & Zhixiong Zhuang. (2011) Epigenetic regulation mechanism of ABCG2 induced drug-resistant phenotype. Journal of Medical Colleges of PLA 26:5, pages 243-253.
Crossref
Dan Zhu, Stephen B. Hunter, Paula M. Vertino & Erwin G. Van Meir. (2011) Overexpression of MBD2 in Glioblastoma Maintains Epigenetic Silencing and Inhibits the Antiangiogenic Function of the Tumor Suppressor Gene BAI1 . Cancer Research 71:17, pages 5859-5870.
Crossref
Antonio Porro, Nunzio Iraci, Simona Soverini, Daniel Diolaiti, Samuele Gherardi, Carolina Terragna, Sandra Durante, Emanuele Valli, Thea Kalebic, Roberto Bernardoni, Chiara Perrod, Michelle Haber, Murray D. Norris, Michele Baccarani, Giovanni Martinelli & Giovanni Perini. (2011) c-MYC Oncoprotein Dictates Transcriptional Profiles of ATP-Binding Cassette Transporter Genes in Chronic Myelogenous Leukemia CD34+ Hematopoietic Progenitor Cells. Molecular Cancer Research 9:8, pages 1054-1066.
Crossref
Hiroshi Hirata, Yuji Hinoda, Koichi Nakajima, Ken Kawamoto, Nobuyuki Kikuno, Koji Ueno, Soichiro Yamamura, Mohd S. Zaman, Gaurav Khatri, Yi Chen, Sharanjot Saini, Shahana Majid, Guoren Deng, Nobuhisa Ishii & Rajvir Dahiya. (2011) Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. International Journal of Cancer 128:8, pages 1793-1803.
Crossref
Kenneth K.W. To, Robert Robey, Zhirong Zhan, Lois Bangiolo & Susan E. Bates. (2011) Upregulation of ABCG2 by Romidepsin via the Aryl Hydrocarbon Receptor Pathway. Molecular Cancer Research 9:4, pages 516-527.
Crossref
Amanda M Hoffman & Paul Cairns. (2011) Epigenetics of kidney cancer and bladder cancer. Epigenomics 3:1, pages 19-34.
Crossref
Madhumita Pradhan, Leslie A. Bembinster, Sarah C. Baumgarten & Jonna Frasor. (2010) Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter Gene ABCG2 through Estrogen Receptor and NFκB Cooperativity at Adjacent Response Elements. Journal of Biological Chemistry 285:41, pages 31100-31106.
Crossref
F Wang, X Xue, J Wei, Y An, J Yao, H Cai, J Wu, C Dai, Z Qian, Z Xu & Y Miao. (2010) hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. British Journal of Cancer 103:4, pages 567-574.
Crossref
Te Liu, Fuhui Xu, Xiling Du, Dongmei Lai, Tianjin Liu, Yarui Zhao, Qin Huang, Lizhen Jiang, Wenbin Huang, Weiwei Cheng & Zhixue Liu. (2010) Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1. Molecular and Cellular Biochemistry 340:1-2, pages 265-273.
Crossref
J.R. Hutson, G. Koren & S.G. Matthews. (2010) Placental P-glycoprotein and breast cancer resistance protein: Influence of polymorphisms on fetal drug exposure and physiology. Placenta 31:5, pages 351-357.
Crossref
Masatsugu Hiraki, Yoshihiko Kitajima, Seiji Sato, Mayumi Mitsuno, Yasuo Koga, Jun Nakamura, Kazuyoshi Hashiguchi, Hirokazu Noshiro & Kohji Miyazaki. (2009) Aberrant Gene Methylation in the Lymph Nodes Provides a Possible Marker for Diagnosing Micrometastasis in Gastric Cancer. Annals of Surgical Oncology 17:4, pages 1177-1186.
Crossref
Xi-wei Ding, Jun-hua Wu & Chun-ping Jiang. (2010) ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sciences 86:17-18, pages 631-637.
Crossref
Eran E. Bram, Michal Stark, Shachar Raz & Yehuda G. Assaraf. (2009) Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance. Neoplasia 11:12, pages 1359-IN11.
Crossref
Kenneth K.W. To, Robert W. Robey, Turid Knutsen, Zhirong Zhan, Thomas Ried & Susan E. Bates. (2009) Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Molecular Cancer Therapeutics 8:10, pages 2959-2968.
Crossref
Hirendra Nath BanerjeeMukesh Verma. (2009) Epigenetic mechanisms in cancer. Biomarkers in Medicine 3:4, pages 397-410.
Crossref
Stefanie Hauswald, Jesus Duque-Afonso, Michaela M. Wagner, Florian M. Schertl, Michael Lübbert, Christian Peschel, Ulrich Keller & Thomas Licht. (2009) Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes. Clinical Cancer Research 15:11, pages 3705-3715.
Crossref
Yu-Zhuo Pan, Marilyn E. Morris & Ai-Ming Yu. (2009) MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells. Molecular Pharmacology 75:6, pages 1374-1379.
Crossref
Clara Lemos, Ietje Kathmann, Elisa Giovannetti, Jeroen A.M. Beliën, George L. Scheffer, Conceição Calhau, Gerrit Jansen & Godefridus J. Peters. (2009) Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins. Molecular Cancer Therapeutics 8:3, pages 655-664.
Crossref
Joost W. van der Heijden, Ruud Oerlemans, Paul P. Tak, Yehuda G. Assaraf, Maarten C. Kraan, George L. Scheffer, Conny J. van der Laken, Willem F. Lems, Rik J. Scheper, Ben A. C. Dijkmans & Gerrit Jansen. (2009) Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide. Arthritis & Rheumatism 60:3, pages 669-677.
Crossref
Robert W. Robey, Kenneth K.K. To, Orsolya Polgar, Marius Dohse, Patricia Fetsch, Michael Dean & Susan E. Bates. (2009) ABCG2: A perspective. Advanced Drug Delivery Reviews 61:1, pages 3-13.
Crossref
Gergely Szakács, Kenneth Kin Wah, Orsolya Polgár, Robert W. Robey & Susan E. Bates. 2009. Drug Resistance in Cancer Cells. Drug Resistance in Cancer Cells 1 20 .
Lei Cui, Li-Yan Xu, Zhong-Ying Shen, Qian Tao, Shu-Ying Gao, Zhuo Lv, Ze-Peng Du, Wang-Kai Fang & En-Min Li. (2008) NGALR Is Overexpressed and Regulated by Hypomethylation in Esophageal Squamous Cell Carcinoma . Clinical Cancer Research 14:23, pages 7674-7681.
Crossref
Qingcheng Mao. (2008) BCRP/ABCG2 in the Placenta: Expression, Function and Regulation. Pharmaceutical Research 25:6, pages 1244-1255.
Crossref
A M Calcagno, J M Fostel, K K W To, C D Salcido, S E Martin, K J Chewning, C-P Wu, L Varticovski, S E Bates, N J Caplen & S V Ambudkar. (2008) Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. British Journal of Cancer 98:9, pages 1515-1524.
Crossref
Balasubramanian Poonkuzhali, Jatinder Lamba, Stephen Strom, Alex Sparreboom, Kenneth Thummel, Paul Watkins & Erin Schuetz. (2008) Association of Breast Cancer Resistance Protein/ABCG2 Phenotypes and Novel Promoter and Intron 1 Single Nucleotide Polymorphisms. Drug Metabolism and Disposition 36:4, pages 780-795.
Crossref
Honggang Wang, Eun-Woo Lee, Lin Zhou, Peter C. K. Leung, Douglas D. Ross, Jashvant D. Unadkat & Qingcheng Mao. (2008) Progesterone Receptor (PR) Isoforms PRA and PRB Differentially Regulate Expression of the Breast Cancer Resistance Protein in Human Placental Choriocarcinoma BeWo Cells. Molecular Pharmacology 73:3, pages 845-854.
Crossref
Hirofumi Nakano, Yoichi Nakamura, Hiroshi Soda, Megumi Kamikatahira, Kanako Uchida, Mineyo Takasu, Takeshi Kitazaki, Hiroyuki Yamaguchi, Katsumi Nakatomi, Katsunori Yanagihara, Shigeru Kohno & Kazuhiro Tsukamoto. (2008) Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells. Cancer 112:5, pages 1122-1130.
Crossref
Kenneth K.W. To, Orsolya Polgar, Lyn M. Huff, Kuniaki Morisaki & Susan E. Bates. (2008) Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells . Molecular Cancer Research 6:1, pages 151-164.
Crossref
Jun Hu, Jian Li, Min Wang, Zhiyong Du, Min Chen & Renyi Qin. (2007) Isolation of side population cells from gallbladder carcinoma of human being and the expression of ABCG2 gene. The Chinese-German Journal of Clinical Oncology 6:5, pages 469-473.
Crossref
Robert W. Robey, Orsolya Polgar, John Deeken, Kin Wah To & Susan E. Bates. (2007) ABCG2: determining its relevance in clinical drug resistance. Cancer and Metastasis Reviews 26:1, pages 39-57.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.